Related Articles
AUA 2024: N-803 plus BCG Complete Response Rate in Non Muscle Invasive Bladder Cancer CIS Subjects: BCG Refractory, Relapsed, Checkpoint Failure, and Chemotherapy Failure; Updated Results (QUILT 3.032)
AUA 2024, N-803 plus BCG, Non Muscle Invasive Bladder Cancer (NMIBC), BCG Refractory, QUILT 3032 trial, ANKTIVA, interleukin-15 superagonist (IL-15), BCG-unresponsive high-grade NMIBC.
AUA 2024: Replacing ReTUR with Cystoscopy in High-Grade T1 NMIBC Patients: Confirmatory Results from the HuNIRe Trial
AUA 2024, non-muscle invasive bladder cancer (NMIBC), trans urethral resection of bladder tumor (TURBT), HG T1 bladder cancer, Replacing ReTUR with Cystoscopy, HuNIRe trial, urine cytology,…
AUA 2024: Challenging the Paradigm of “BCG Unresponsive” Bladder Cancer: Does Additional BCG Have an Effect?
AUA 2024 efficacy of repeat BCG challenge in patients with “BCG unresponsive” non-muscle invasive bladder cancer (NMIBC), BCG-unresponsive NMIBC,
AUA 2024: Rates and Predictors of False Node-Positive PSMA-PET in Patients Treated with Radical Prostatectomy and Extend Pelvic Lymph-Node Dissection: Results From a Large, Multi-Institutional Database
AUA 2024 advanced prostate cancer, molecular imaging (mi) node positive disease (miN1) undergoing radical prostatectomy, extended pelvic lymph node dissection (ePLND).
Adjuvant Pembrolizumab in Urothelial Carcinoma: AMBASSADOR Study Findings – Andrea Apolo
Andrea Apolo joins Sam Chang in discussing the AMBASSADOR study, focusing on adjuvant pembrolizumab for muscle-invasive urothelial carcinoma. The study showed improved disease-free survival with…
AUA 2024: Third Interim Analysis of the DARolutamide ObservationaL (DAROL) Study in Patients with Nonmetastatic Castration-Resistant Prostate Cancer
AUA 2024 third interim analysis of the DARolutamide ObservationaL (DAROL) study, nonmetastatic castration-resistant prostate cancer (nmCRPC), DAROL study, darolutamide, phase 3 ARAMIS trial.
AUA 2024: Effects of Neoadjuvant Chemotherapy on Rates of Depression in Muscle Invasive Bladder Cancer
AUA 2024, muscle-invasive bladder cancer (MIBC), depression in muscle-invasive bladder cancer patients, neoadjuvant chemotherapy (NAC), Effects of Neoadjuvant Chemotherapy on Rates of Depression.
Functional Recovery after Partial Nephrectomy in a Solitary Kidney – Beyond the Abstract
renal mass, renal cell carcinoma (RCC), kidney cancer, Partial Nephrectomy (PN), Radical Nephrectomy (RN), renal mass in a solitary kidney (RMSK), chronic kidney disease (CKD),…
AUA 2024: Phase I Dose-Escalation Trial of Multiple and Fractionated-Dose PSMA-Targeted Alpha Radionuclide (225Ac-J591) for Metastatic Castration-Resistant Prostate Cancer
AUA 2024 results of a phase 1 dose-escalation trial of multiple and fractionated-dose PSMA-targeted alpha radionuclide 225Ac-J591, metastatic castration-resistant prostate cancer (mCRPC), advanced prostate cancer.
AUA 2024: Smoking Status is Associated with Poor Mental Health in Bladder Cancer Patients and Survivors
AUA 2024, bladder cancer, smoking effects on bladder cancer, adverse cancer effects from smoking, smoking effects on mental health.